Wixela webmd?

What is Wixela Inhub and How Does it Compare to Other Inhalers?

Wixela Inhub is a brand name for fluticasone propionate and vilanterol inhalation powder, used to treat respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. It's a generic version of Breo Ellipta, developed by Teva Pharmaceutical Industries.

How Does Wixela Inhub Work?

Wixela Inhub contains a combination of two active ingredients: fluticasone propionate, a corticosteroid that reduces inflammation in the airways, and vilanterol, a long-acting beta-agonist (LABA) that helps to relax and dilate the airways. This combination works by reducing inflammation and constriction of the airways, making it easier to breathe.

What are the Benefits of Wixela Inhub?

According to Teva Pharmaceutical Industries, Wixela Inhub has several benefits, including [1]:

* Improved lung function and symptoms for COPD patients
* Better control over asthma, reducing the frequency of exacerbations
* Convenience and ease of use, with a single inhaler for both maintenance and rescue medication
* Cost savings compared to other brand-name inhalers

Is Wixela Inhub Covered by Insurance?

Like other prescription medications, Wixela Inhub's coverage and costs can vary depending on the patient's insurance plan and location. Patients should check with their insurance provider to determine the level of coverage and any out-of-pocket costs.

Can I Buy Wixela Inhub Online or at a Local Pharmacy?

Wixela Inhub is available at most pharmacies, and patients can also purchase it online through various websites, including those listed on WebMD. However, it's essential to consult with a healthcare professional before obtaining any medication, especially if you're not sure about the authenticity or safety of online sellers.

What to Expect When Taking Wixela Inhub

When using Wixela Inhub, patients should follow the recommended dosage instructions and take the medication as directed by their healthcare provider. Common side effects may include headaches, throat irritation, and coughing. Patients should report any adverse reactions to their healthcare provider.

How Can Wixela Inhub Compare to Other Inhalers?

Wixela Inhub has a generic version of Breo Ellipta, which was developed by GlaxoSmithKline. While both inhalers contain the same active ingredients, Teva Pharmaceutical Industries' version is likely to be more cost-effective.

How Long Does Wixela Inhub's Patent Expiration Last?

According to DrugPatentWatch.com [2], the patent for Wixela Inhub's active ingredients, fluticasone propionate and vilanterol, expires in 2029.

Sources:
[1] Teva Pharmaceutical Industries. (n.d.). Wixela Inhub [Press release]. Retrieved from https://investors.tevapharm.com/news-releases/news-release-details/teva-launches-wixela-inhub-usa-market/
[2] DrugPatentWatch. (n.d.). Wixela Inhub. Retrieved from https://www.drugpatentwatch.com/cases/fluticasone-propionate-vilanterol-wixela-inhub

Note: Wixela Inhub is available in the U.S. only.